Helicobacter pylori vaccine (GlaxoSmithKline)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHelicobacter pylori vaccine (GlaxoSmithKline)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcUniversity Of SienaNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Vaccines
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A
Related LinksN/A